Pharmaceutical Executive: March 2025 Interactive Digital Edition

Publication
Article
Pharmaceutical ExecutivePharmaceutical Executive: March 2025
Volume 45
Issue 2

View the Pharmaceutical Executive March 2025 issue in an interactive format.

Click here to view our interactive March 2025 issue!

Download Issue PDF
Articles in this issue
Pharmaceutical Executive: March 2025 Interactive Digital Edition
Pharmaceutical Executive: March 2025 Interactive Digital Edition
High Impact
High Impact
Mark Frohlich: A ‘Natural’ Leader
Mark Frohlich: A ‘Natural’ Leader
Emerging Biopharma Launches: Strategizing in Today’s Global Market
Emerging Biopharma Launches: Strategizing in Today’s Global Market
The ‘People Factor’: Sourcing, Nurturing, and Retaining Talent
The ‘People Factor’: Sourcing, Nurturing, and Retaining Talent
AI-Enabled Benchmarking: Transforming Performance Measurement for Pharma Brands
AI-Enabled Benchmarking: Transforming Performance Measurement for Pharma Brands
FDA’s New Accelerated Approval Draft Guidance
FDA’s New Accelerated Approval Draft Guidance
The Virtual Reality of Modern Pharma Sales and Marketing
The Virtual Reality of Modern Pharma Sales and Marketing
Beyond the Data: Making HCP Analytics Actually Work for Commercial Teams
Beyond the Data: Making HCP Analytics Actually Work for Commercial Teams
Recent Videos
Fred Aslan
Gameto - Addressing Regulatory Hurdles in iPSC-Based Fertility
Fred Aslan
Dr. Dina Radenkovic, CEO, Gameto
Recent Regulatory Impacts on the Pain-Management Space
Fred Aslan
Fred Aslan
Related Content
Azurity Pharmaceuticals Completes Covis Pharma Acquisition

Azurity Pharmaceuticals Completes Covis Pharma Acquisition

Don Tracy, Associate Editor
March 14th 2025
Article

Deal to acquire Covis is expected to expand Azurity’s portfolio across multiple complex dosage forms and key therapeutics areas.

Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more

Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more

Miranda Schmalfuhs
March 14th 2025
Article

The latest news for pharma industry insiders.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment

Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment

Don Tracy, Associate Editor
March 14th 2025
Article

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva maintaining high viral suppression rates.

Mark Frohlich: A ‘Natural’ Leader

Mark Frohlich: A ‘Natural’ Leader

Mike Hollan
March 13th 2025
Article

Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer cells to reshape treatment for cancer and autoimmune disease.